ARTICLE SYNOPSIS...Pfizer broke channel resistance with good volume on the 30-minute chart, enough to reverse the short-term downtrend.
ARTICLE SYNOPSIS...Shares of Pfizer, Inc., have been surging higher since mid-November 2012. Can the stock break above its previous high of 26.09 sometime between now and late January 2013?
ARTICLE SYNOPSIS...Already in an uptrend for more than 15 months, shares of Pfizer Inc. have fired yet another buy signal.
ARTICLE SYNOPSIS...A positive divergence sets shares of Pfizer up for a test of resistance at the 50-day exponential moving average.
ARTICLE SYNOPSIS...Pfizer (PFE) has come off its recent peak. Is this the start of a bigger downleg or just a normal correction?
ARTICLE SYNOPSIS...Here's a short-term outlook to Pfizer, using short-term indicators.
ARTICLE SYNOPSIS...See why an interesting historical precedent could provide clues in 2020.
ARTICLE SYNOPSIS...Pfizer shares may be ready to move lower still, based on the trend dynamics on its daily and weekly charts.
ARTICLE SYNOPSIS...The bearish phase of Pfizer is likely to end.
ARTICLE SYNOPSIS...Pfizer shares may be on the verge of a larger, more sustained downtrend over the next few weeks.
ARTICLE SYNOPSIS...This statistical analysis shows Pfizer is now entering into a long-term bear market trend.
ARTICLE SYNOPSIS...The bears are ready to engulf the bullish rally of Pfizer.
ARTICLE SYNOPSIS...Pfizer has been underperforming for many years. But now there are signs the stock could see a bullish makeover.
ARTICLE SYNOPSIS...Statistical analysis is used to show that Pfizer is in the process of reversing its intermediate-term trend from up to down.
ARTICLE SYNOPSIS...Statistical analysis shows Pfizer in the process of turning down.
ARTICLE SYNOPSIS...With the Obama health plan coming into play in spite of opposition, is it worthwhile to invest in pharmaceutical companies?
ARTICLE SYNOPSIS...A small range-bound rally may complete the cup with handle pattern. The bullish breakout of the pattern may attract new traders.
ARTICLE SYNOPSIS...After being plagued by drug problems in 2004, Pfizer rebounded throughout 2005. However, bearish candlesticks and waning momentum suggest an end to the current rally.
ARTICLE SYNOPSIS...Pfizer Inc. is an established downtrend. Has its recent upside correction put it in a position to short?
ARTICLE SYNOPSIS...The stock is testing the lower trendline of a channel that contains prices during the past months' downtrend.
ARTICLE SYNOPSIS...The volatility has turned wild as this stock started to trade in a narrower range, experiencing choppy trading sessions.
ARTICLE SYNOPSIS...Pfizer is a pharmaceutical company headquartered in New York City.
ARTICLE SYNOPSIS...Prices could continue to move up and close the gap in the $24 area.
ARTICLE SYNOPSIS...Drug companies have suddenly decided to bare their souls, and those of their drugs. Will they bounce back, and is the risk worth taking?